chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Isn't feeling good; Hard for him to walk straight; Coughing a little; Achy; Nauseous; Headache; Temperature of 101 degrees F; Little soreness to the touch at the injection site; This spontaneous case was reported by a consumer and describes the occurrence of FEELING ABNORMAL (Isn't feeling good), GAIT DISTURBANCE (Hard for him to walk straight), COUGH (Coughing a little), PAIN (Achy) and VACCINATION SITE PAIN (Little soreness to the touch at the injection site) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 030M20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included COVID-19 (He had COVID for three weeks in December 2020.) in December 2020. Concomitant products included CUCURBITA PEPO OIL, SERENOA REPENS, ZINC GLUCONATE (SAW PALMETTO [CUCURBITA PEPO OIL;SERENOA REPENS;ZINC GLUCONATE]), ACETYLSALICYLIC ACID (BABY ASPIRIN), VITAMINS NOS and LISINOPRIL for an unknown indication.    On 10-Feb-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, the patient experienced VACCINATION SITE PAIN (Little soreness to the touch at the injection site). On 11-Feb-2021, the patient experienced FEELING ABNORMAL (Isn't feeling good), GAIT DISTURBANCE (Hard for him to walk straight), COUGH (Coughing a little), PAIN (Achy), NAUSEA (Nauseous), HEADACHE (Headache) and PYREXIA (Temperature of 101 degrees F). At the time of the report, FEELING ABNORMAL (Isn't feeling good), GAIT DISTURBANCE (Hard for him to walk straight), COUGH (Coughing a little), PAIN (Achy), VACCINATION SITE PAIN (Little soreness to the touch at the injection site), NAUSEA (Nauseous), HEADACHE (Headache) and PYREXIA (Temperature of 101 degrees F) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 11-Feb-2021, Pyrexia: 101 101 degrees F.     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment information not provided.    This case was linked to MOD21-027453 (Patient Link).
vaccine given after the published expiry date.; This spontaneous case was reported by an other health care professional and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (vaccine given after the published expiry date.) in a 66-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 060H21A) for COVID-19 vaccination.     No Medical History information was reported.    On 02-Apr-2022, the patient received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Apr-2022, the patient experienced EXPIRED PRODUCT ADMINISTERED (vaccine given after the published expiry date.). At the time of the report, EXPIRED PRODUCT ADMINISTERED (vaccine given after the published expiry date.) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   No concomitant medications reported. No treatment information was provided.
Initial report received from a healthcare professional on 30 October 2012. A 38-year-old female patient, whose medical history included hypothyroidism and concomitant medications were not reported, had received an intradermal dose of FLUZONE ID (lot number: UT4471AA) in left deltoid on 29 September 2012. The patient had no illness at the time of vaccination. The patient had no known allergies. The patient had received numerous flu vaccines. On 30 September 2012, 1 day after vaccination, the patient had experienced left upper arm to shoulder redness, sore and hot to touch. Laboratory investigations and corrective medications were not reported. The patient's outcome was not recovered. Follow-up information was received from a healthcare professional on 01 February 2013. Based upon follow-up information this case has been upgraded to serious. The patient required Prednisone 20mg two tablets daily for 5 days in order to treat reaction. Outcome remained not recovered. Documents held by sender: none.
Headache, Myalgia, Arthralgia, Fever, CoughWheeze, site soreness, fever, joint pain and stiffness, headache, malaise, fatigue, upper respiratory (drainage and cough, sore throat) after 2nd dose Narrative: aspirin, Tylenol, Dayquil
Swelling of injection site with raised red places, low grade fever (100 degrees), general unwell feeling.
Information was received from an immunization program of a community nursing service concerning a patient (demographics not provided). On an unknown date, the patient was vaccinated with GARDASIL, lot # J003727 (exp. 07-NOV-2015) (dosage and route of administration not provided). The vaccine was reported to have been improperly stored. Additional information has been requested.
24 hours after his vaccination, patient had two patches of petechiae and purpura on his anterior thighs. His CBC, CMP, and sed rate were normal. There is no history of trauma. He is well with no other symptoms. No prior similar reactions or rashes.   While I haven't seen this type of non-ITP associated rash before, he is completely well and because of the timing of his flu shot, thought I should make the report.
headache, body aches, vomiting, nausea, fever, chills, nasal congestion, coughing, severe tiredness, rash on torso; went to Urgent Care on 5/10/2022 with a week long of continued symptoms and was placed on amoxicillin.
Fussiness and congestion, post vax. 1 1/2 days later, developed eye and lip swelling. No difficulty breathing and no rash. Given Benadryl with improvement.
After I got my first vaccine dose I noticed a few heart palpitations.  They weren't too bad so I only mentioned it to the pharmacist before I got my second dose.  I asked her if she has had any other patient say they had heart palpitations after getting the shot.  She said she hadn't heard of it and asked if I still wanted to get it.  I told her yes because she didn't seem too worried.  After getting my second dose I noticed that same day LOTS of heart flutters and palpitations!  I ended up calling the after hours nurse that night because I was worried about it.  The nurse told me that if I am not having chest pain or shortness of breath to probably not worry about it.  For the next 5 after getting the shot I had major heart flutters and palpitations almost constantly.  I made an appointment with a doctor but the soonest they had was the following week.  After the 5 day I noticed my heart calming down.  SInce then I don't feel my heart has been the same.  I don't have the flutters nearly as much but I notice it beating harder and just "off".  I don't feel that if I went to the doctor they would be able to do anything for me because it's not bad enough.  I am still grateful to have gotten the vaccine but I am so so so sad that I have had this reaction and pray my hear will heal to how it was before.  I don't feel safe to get any boosters or further vaccines though.
Severe pain in left shoulder & arm starting at 2:30am, the night after injection, and getting worse during the following day and spreading to back of neck and shoulders and upper chest.  Severe pain has lasted into today July 22.
No adverse event; Patient have been administered vaccine after the published expiration date.; This spontaneous case was reported by a pharmacist and describes the occurrence of EXPIRED PRODUCT ADMINISTERED (Patient have been administered vaccine after the published expiration date.) and NO ADVERSE EVENT (No adverse event) in a 70-year-old female patient who received mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (batch no. 065H22A) for COVID-19 prophylaxis.     The patient's past medical history included COVID-19 (Patient has been diagnosed with/tested positive for covid-19.).    On 26-Aug-2023 at 2:28 PM, the patient received dose of mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (unknown route) .5 milliliter. On 26-Aug-2023 at 2:28 PM,  after starting mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)), the patient experienced EXPIRED PRODUCT ADMINISTERED (Patient have been administered vaccine after the published expiration date.). On an unknown date, the patient experienced NO ADVERSE EVENT (No adverse event). At the time of the report, EXPIRED PRODUCT ADMINISTERED (Patient have been administered vaccine after the published expiration date.) and NO ADVERSE EVENT (No adverse event) outcome was unknown.        For mRNA-1273 BIVALENT .222 (MODERNA COVID-19 VACCINE, BIVALENT (ORIGINAL AND OMICRON BA.4/BA.5)) (Unknown), the reporter considered NO ADVERSE EVENT (No adverse event) to be not related. No further causality assessment was provided for EXPIRED PRODUCT ADMINISTERED (Patient have been administered vaccine after the published expiration date.).    Concomitant product use was not provided by the reporter. Patient has no acute illnesses at the time of vaccination and up to one month before. It has been reported that vaccines were in special deep freezer setup for the storage. Treatment information was not provided.   Most recent FOLLOW-UP information incorporated above includes: On 05-Sep-2023: Follow up has significant information: Report type has been updated from invalid to spontaneous. Reporter detail, Patient demographics, other relevant history, vaccine Information, Event verbatim and I-narrative has been updated.
Nurse administered Moderna 6mo-5yr vaccine instead of Moderna 6yr-11yr vaccine. Parent was notified and child was scheduled to return to clinic to recieve correct vaccine.
Patient presenting to ED with intermittent chest pain with mild shortness of breath that began 2 weeks ago.  Pain started gradually.  She states symptoms began after receiving the COVID-19 vaccination to the left arm.  It is described as "numbness" radiating into the left arm. Pain is described as moderate upon onset and is currently mild. Patient was stabilized and prescribed Ibuprofen 400mg, and given strict return precautions if symptoms persist.
Headaches, underarm glands swollen, body aches, soreness, redness of arm, fever near area
Roof of mouth enflamed; raw like road rash especially behind upper front teeth but also toward the back and the pallet.; Separately, Random pain spots ie, ball of left foot, left psoas area muscle.; This is a spontaneous report from a contactable consumer, the patient. A 63-years old female non pregnant patient received second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE (Lot number: EP6955) via the left arm on 16Mar2021 as a single dose for Covid-19 immunisation. The patients medical history includes no/possible fibromyalgia. Concomitant medications were not reported. The patient was diagnosed with COVID-19 prior to vaccination. The patient had not tested positive for COVID-19 since having the vaccine. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE [Lot number: EL9261] via the left arm on 21Feb2021 as a single dose for Covid-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 19Mar2021, the patient experienced events of roof of mouth enflamed, raw like road rash especially behind upper front teeth but also toward the back and the pallet. The patient also reported separately, random pain spots ie, ball of left foot, left psoas area muscle. The patient did not receive any treatment for the reported events. The clinical outcome of the events roof of mouth enflamed, raw like road rash especially behind upper front teeth but also toward the back and the pallet and separately, Random pain spots ie, ball of left foot, left psoas area muscle was not recovered at the time of this report.   No follow-up attempts are needed. No further information is expected.
After receiving the third dose of Pfizer I started having brain fog, fatigue, chills and the next day I had all over body, joint, and muscle pain. I had Costochondritis, and I was given methocarbamol for the prior doses so I just used these medications to treat the pain. This event lasted for 3 days in total.
Varicella Information has been received from a certified medical assistant (CMA) concerning a 4 year old white female who on 10-JAN-2003 was vaccinated SC in the right arm with a dose of varicella virus vaccine live (Oka/Merck) (Lot #641155/0793M). The CMA reported that on 12-JAN-2006 the patient developed chickenpox. Symptomatic care was discussed with the patient's mother. On 20-JAN-2006 the patient's chickenpox resolved. No further information is available.
Patient was administered Moderna vaccine that should have been removed from the fridge and discarded 3 days prior.
13.5 cm x 10.5 cm area of induration surrounding injection site with smaller 4cm x 5cm more erythematous induration at injection site.
DRUG USED TO PATIENT OF INAPPROPRIATE AGE; OFF LABEL USE POPULATION; This spontaneous report received from a health care professional concerned a 17 year old of unspecified sex. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported.  The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unk) dose was not reported, administered on 10-JUN-2021 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 10-JUN-2021, the subject experienced drug used to subject of inappropriate age. On 10-JUN-2021, the subject experienced off label use population. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the drug used to patient of inappropriate age and off label use population was not reported. This report was non-serious.
doses administered after more than 1 temperature excursion; doses administered after more than 1 temperature excursion; This spontaneous case was reported by an other health care professional and describes the occurrence of POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) in a 63-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 014M20A and 019B21A) for COVID-19 vaccination.     No Medical History information was reported.   On 27-Feb-2021 at 3:43 PM, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) .5 milliliter. On 28-Mar-2021 at 1:17 PM, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to .5 milliliter. On 27-Feb-2021 at 3:43 PM, the patient experienced POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion). On an unknown date, the patient experienced PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion). At the time of the report, POOR QUALITY PRODUCT ADMINISTERED (doses administered after more than 1 temperature excursion) and PRODUCT TEMPERATURE EXCURSION ISSUE (doses administered after more than 1 temperature excursion) outcome was unknown.        For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   The patient age was reported as 63.78 (at the time of 1st dose) and 63.86 (2nd dose) years.  No concomitant product use was reported.  It was reported that unknown number of patients were administered with vaccines that experienced more than 1 temperature excursion during 33 weeks in 2021. The HCP explained that each time a vial was put into a cooler, there was a period of time of 1 hour or 1 hour and a half approximately, when the temperature data logger registered 34 or 35 degree F.    On 27-Feb-2021, total doses given for the day was 199, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 24-Feb-2021, vial was moved to clinic on 27-Feb-2021. 20 vials were moved to clinic. Vaccine BUD date was 26-Mar-2021 for batch number 014M20A.  On 28-Mar-2021, total doses given for the day was 150, condition of vaccine prior to vaccination was not frozen, vaccine was moved to fridge on 23-Mar-2021, vial was moved to clinic on 27-Mar-2021. 15 vial was moved to clinic. Vaccine BUD date was 22-Apr-2021 for batch number 019B21A.  Vials only punctured right before administration.  No treatment information was provided.
Had headache 9:30 A-then started throwing up later, otherwise feels fine. Is 11 weeks pregnant. Advised to go to ER.  11/17/09 Medical  records received for DOS 10/21/09. After hours care notes. Assessment gastroenteritis vs morning sickness. 11 Weeks gestation. Vomiting x7 s/p vaccine., Flushed. Looks ill.  Low grade temp.
Pt was brought in to local health dept for what we thought was the 2nd Moderna shot. After patient was dosed, the immunization from the web was given to CNA and it was discovered at that time that patient had previously been vaccinated on 1/30/2021, 3/18/2021,  4/21/2021 and 6/2/2021. This nurse called back to the nursing home to verify information (DOB/name), also called PCP and Hospital where patient was in and out of, along with the Health Department. Spoke with the Health Dept and they did verify that they dosed this patient on the first 2 dates mentioned above. Consents were faxed to the Health Dept. This nurse called back to Nursing home speaking to director of nursing each time and reported this event. Director of nursing stated they would monitor the patient closer. Director of nursing stated that she didn't know if the web was checked upon admission into their facility on 4/9/2021. Nurse further called patient's PCP and family to inform what happened. This nurse called state to report incident and find out what else needed done. County Administrator was also informed.
Joint Pain, increase skeletal Pain, Fever, Chills, Stiffneck, difficulty Walking. Started 8Hrs after injection. Aem Swelling/Redness from elbow to shoulder, Tylenol/ASA for pain.
After the shot I felt fine. Four days later I was sent home, I had respiratory issues. I developed pneumonia in my lungs
Tachycardia worsening; Intermittent chest pain; Nausea; legs were numb, numbness and tingling in both hands, both feetintermittently on face,; Muscle aches; arm was really sore; hand was really numb, numbness in L hand; really severe fatigue; threw up once; This spontaneous case was reported by a physician and describes the occurrence of VACCINATION SITE PAIN (arm was really sore), HYPOAESTHESIA (hand was really numb, numbness in L hand), FATIGUE (really severe fatigue), VOMITING (threw up once) and HYPOAESTHESIA (legs were numb, numbness and tingling in both hands, both feetintermittently on face,) in a 30-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 006MZ0A and 011620A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     Concomitant products included IBUPROFEN for Adverse event, ETHINYLESTRADIOL, FERROUS FUMARATE, NORETHISTERONE ACETATE (LARIN FE) for Birth control pill.   On 23-Jan-2021, the patient received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 20-Feb-2021, received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 21-Feb-2021, the patient experienced VACCINATION SITE PAIN (arm was really sore), HYPOAESTHESIA (hand was really numb, numbness in L hand), FATIGUE (really severe fatigue) and VOMITING (threw up once). On 23-Feb-2021, the patient experienced HYPOAESTHESIA (legs were numb, numbness and tingling in both hands, both feetintermittently on face,) and MYALGIA (Muscle aches). On 24-Feb-2021, the patient experienced CHEST PAIN (Intermittent chest pain) and NAUSEA (Nausea). On 26-Feb-2021, the patient experienced TACHYCARDIA (Tachycardia worsening). The patient was treated with STEROIDS for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION SITE PAIN (arm was really sore), HYPOAESTHESIA (hand was really numb, numbness in L hand), FATIGUE (really severe fatigue), VOMITING (threw up once), HYPOAESTHESIA (legs were numb, numbness and tingling in both hands, both feetintermittently on face,), MYALGIA (Muscle aches), CHEST PAIN (Intermittent chest pain), NAUSEA (Nausea) and TACHYCARDIA (Tachycardia worsening) outcome was unknown. Not Provided      For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Patient reports visiting Urgent Care on 24-FEB-2021 for treatment of symptoms.  Patient saw her Primary Care Physician on 26-feb-2021.  Again on 12-MAR-2021, patient saw her PCP and reports Blood Work (NOS) was done.  No results were provided.  On 17-Mar-2021 patient reports seeing PCP again for follow up visit and reports LABS (NOS) were normal.
dizziness, disoriented , could not stand, headache, could not stand, does not remember any of time after shot. , loss function of extremities., responded to pain , does not remember anything in ER was kept in hospital 4 days , began to move extremeties after 3 days. Extreme weakness in body , did not  have awareness and body movements for several days.
Severe fatigue onset 5 hours following injection. 24 hours after, developed migraine,  fever, chills, vomiting and diarrhea last app. 24 hours. Day 3 and 4 severe fatigue, body and joint aches, migraine, mild nausea.
I broke out and the doctor said I might have chicken pox, but I had to go to the eye physician and it really effected my eyes. My face broke out really bad. I went to the dermatologist, and she gave me a medicine. My face got back after a month I still have some spots on my face.
Period came on when not supposed to-constantly bleeding for 3 weeks. Increase in unaware seizures-set in 1 week after booster and have continued for 2 weeks
Pt recvd Hep B vax on 9JUL91 & next day exp pain in lt arm then a muscle spasm in upper back which then migrated down to lower back; tx Advil; sx persisted for approx 1 mon; pain in lt arm subsided;
Headache, Sedation, Myalgia, Arthralgia, SWELLING AND PAIN Narrative:
Racking chills, fever, head and neck ache: 10 hours post-vaccine to 18 hours post-vaccine  Body aches, fever, dizziness, difficulty rising: 12 hours post-vaccine to 24 hours post-vaccine.   Flickering vision/appearance of flashing lights and acute joint pain: 30 hours post-vaccine
Had varicella vaccine 12/7/1998. Has varicella infection today 5/20/04 around 50 lesions, papules, pustules and vesicles- 1 scabbed over. Know chickenpox exposure in school 2 weeks prior.
PT RECIEVED VACCINE PAST THE BEYOND USE DATE. NO ADVERSE EFFECTS REPORTED.
severe local rxn to vax;14x14cm area of erythema & warmth around inj site;
This spontaneous report as received from a physician via a company representative refers to a 17 year old female patient. She had, reportedly, not been feeling well on 16-MAY-2016. Apart from this, information regarding her pertinent medical history and drug reactions/ allergies was unknown. On 17-MAY-2016, the patient was vaccinated with an unspecified dose of GARDASIL 9 (which had a lot number of M003659 and an expiration date of 20-SEP-2017), intramuscularly. Her concomitant therapies included DAYQUIL, which was administered on 16-MAY-2016 since she was not feeling well. Subsequently, on 19-MAY-2016, 2 days the vaccination, the patient came to the physician for follow up visit which comprised of complaints relating to an unspecified neck pain, soreness in her eyes and behind the ears, a sore throat, an unspecified rash, itchy skin and swollen lymph nodes. These events had an onset of an unspecified date in May 2016. No treatment was provided for the adverse events and no product quality complaint was involved. At the time of reporting, the outcome of all the events were unknown. Furthermore, no causal relationship was provided between the events and the vaccination with GARDASIL 9. Additional information has been requested.